Abstract
Objective
The US is considering a very low nicotine content (VLNC) cigarette standard. We sought to characterize the prevalence and correlates of the incorrect belief that VLNC cigarettes are less carcinogenic than current cigarettes, as this could reduce motivation to quit.
Methods
Participants were a nationally-representative sample of 650 adult smokers in the US. In 2015–2016, before the VLNC proposal became public, these smokers took part in an online survey. We used multivariate weighted analyses to calculate odds ratios and percentages and a chi square test to examine the association between variables.
Results
Overall, 47.1% of smokers believed that smoking VLNC cigarettes for 30 years would be less likely to cause cancer than smoking current cigarettes. This misperception was more common among smokers who were age 55+ (56.6%) and black (57.4%). Additionally, 23.9% of smokers reported they would be less likely to quit if the US adopted a VLNC standard. Thinking that VLNC cigarettes would be less carcinogenic was associated with smokers reporting they would be less likely to quit (p < .01).
Conclusions
Many smokers had the misperception that smoking VLNC cigarettes is less likely to cause cancer, and some stated that they would be less likely to quit. A VLNC standard may be more effective if accompanied by a communication campaign that emphasizes the continued dangers of smoking VLNC cigarettes due to the many toxic chemicals in smoke.
INTRODUCTION
In July 2017, the US Food and Drug Administration (FDA) charted a game-changing approach to tobacco regulation: reduce the nicotine in combustible cigarettes and simultaneously encourage innovation in safer nicotine products.[1,2] A nicotine reduction policy involves requiring that the nicotine content in combustible tobacco be reduced to non-addictive levels.[3] The result would be “very low nicotine content” (VLNC) cigarettes.[4,5] Recent studies show VLNC cigarettes lead to less dependence, fewer cigarettes smoked per day, and increased quit attempts compared to controls.[6–12] Public support for nicotine reduction is high.[13] A 2015 World Health Organization report has highlighted the potential of nicotine reduction.[4] The US FDA is considering a VLNC product standard, [1,14] and other countries are also exploring VLNC policies.[5,15]
One concern is that the public may misinterpret how VLNC cigarettes are different from current cigarettes, leading to unintended consequences.[16] A widespread (and incorrect) belief is that nicotine is the main carcinogen in cigarettes.[17] This belief may come from the decades of health messaging linking nicotine and smoking, and smoking and cancer. If smokers see VLNC cigarettes as less harmful than current cigarettes, they may be less motivated to quit or to switch to safer nicotine products. We were unable to find any estimates of the national prevalence of the misperception that VLNC cigarettes are less carcinogenic than current cigarettes.[18,19]
We sought to characterize the prevalence and demographic correlates of the misperception that VLNC cigarettes are less carcinogenic than current cigarettes (i.e., the VLNC misperception). This information can prepare regulators for potential unintended consequences and inform communication efforts to correct the misperception. In particular, we hypothesized that the VLNC misperception is less prevalent for smokers with higher educational attainment. People who have more education may be more likely to have learned that nicotine causes addiction but does not directly cause cancer. We also hypothesized that having the VLNC misperception would be associated with lower intention to quit smoking if FDA enacted a VLNC standard.
METHODS
Participants
We identified participants by random digit dialing of US landlines and cellphones, with an approximate coverage of 98% of US households.[20] After completing a phone survey, participants were eligible to take part in a subsequent online VLNC survey Those who did not complete the online survey received a mailed paper survey to complete. Participants completed the survey October 2015 through January 2016, before news of the FDA’s VLNC proposal became public. Of 2,570 adults invited to take the survey, 1,758 completed it, resulting in a response rate of 68.4%. Of the 1,758 adults, 650 were smokers, whose data comprise the analytic sample. One of the survey questions, about the likelihood of quitting, was not included in the print survey, resulting in a lower sample size for that item (n = 354). Further details about the sampling design are available in separate papers.[20,21] Participants received compensation for their time.
Procedures and measures
The survey introduced the concept of VLNC cigarettes and asked about perceived cancer risk from smoking these cigarettes: “Imagine the government required tobacco companies to remove most of the nicotine from cigarettes. Compared to smoking current cigarettes, smoking cigarettes with much less nicotine for 30 years would cause…” The response options were “A lot less risk of lung cancer,” “A little less risk of lung cancer,” “The same risk of lung cancer,” “A little greater risk of lung cancer,” and “A lot greater risk of lung cancer.” We dichotomized these responses to reflect either believing VLNC cigarettes are less carcinogenic than current cigarettes (coded as 1), or believing VLNC cigarettes are equally or more carcinogenic (0). The survey also asked, “If the government required tobacco companies to remove most of the nicotine from cigarettes, would that make you…” The 5-point response scale ranged from “A lot less likely to quit smoking” to “A lot more likely to quit smoking.” We dichotomized these responses to be less likely to quit smoking (1) or equally or more likely to quit smoking (0). The survey also collected demographic information (age, sex, education, poverty, race, Hispanic ethnicity, and sexual orientation) and asked about smoking behavior and cigarette type. The survey measured education as 15 categories (≤ 4th grade through doctorate) that were reduced to 4 categories for analysis. We defined smokers as those who currently smoke “some days” or “every day” and have smoked at least 100 cigarettes in their lifetime.[22] We coded smoking “light,” “ultra light,” “mild,” “gold,” “blue,” or “silver” cigarettes as smoking “light or equivalent” cigarettes.
Data analysis
Percentages and odds ratios were weighted, and frequencies were unweighted. We conducted weighted multivariate logistic regression to examine demographic correlates of the VLNC misperception. The model included the demographic variables (age, sex, education, poverty, race, Hispanic ethnicity, and sexual orientation) and smoking “light” (or equivalent) cigarettes. We also analyzed likelihood of quitting if a VLNC standard was in place, and conducted a chi-square test to determine the association between the VLNC misperception and likelihood of quitting. Analyses were two-tailed, with critical alpha of .05, and conducted using SAS v9.4 (Cary, NC).
RESULTS
The mean age of participants was 43.1 years (range 18–84). Most smokers were white (78.5%) or black (14.9%); 6.2% were Hispanic. Half (50.0%) the smokers were male, and 6.5% were gay, lesbian, or bisexual. Almost half (46.7%) had not attended college, and 29.7% lived in poverty (below the federal poverty level).
Overall, 47.1% of smokers had the VLNC misperception, believing that VLNC cigarettes are less likely to cause cancer than current cigarettes (Table 1). The misperception was more common among smokers ages 55 or older than among smokers ages 18–34 (56.6% vs. 42.0%, AOR = 1.90; 95% CI = 1.14, 3.15). The oldest age group did not differ from smokers ages 35–54. The misperception was more common among black than white smokers (57.4% vs. 45.1%, AOR = 1.67; 95% CI = 1.00, 2.79). The prevalence of the misperception did not differ across education level (p > .10). The prevalence of the misperception was also consistent across sex, poverty, Hispanic ethnicity, and sexual orientation.
Table 1.
Variable | No. with misperception / No. in category | Weighted % | AOR (95% CI) |
---|---|---|---|
| |||
Overall | 316/650 | 47.1 | n/a |
Sex | |||
Female | 174/334 | 52.4 | ref |
Male | 142/316 | 41.9 | 0.73 (0.50, 1.07) |
Age, years | |||
18–34 | 84/208 | 42.0 | ref |
35–54 | 130/268 | 46.1 | 1.30 (0.83, 2.06) |
55+ | 102/174 | 56.6 | 1.90 (1.14, 3.15) |
Race | |||
White | 213/461 | 45.1 | ref |
Black | 79/139 | 57.4 | 1.67 (1.00, 2.79) |
Other | 24/50 | 47.7 | 1.08 (0.49, 2.37) |
Note. Differences between ages 18–34 and 55+, and between white and black races were statistically significant (p < .05). Model also included education, poverty, Hispanic ethnicity, sexual orientation, and smoking “light” or equivalent cigarettes, which were not statistically significant. ref = reference group; AOR = adjusted odds ratio; CI = confidence intervals.
Moreover, 23.9% of smokers reported that they would be less likely to quit smoking if the government required tobacco companies to remove most of the nicotine from cigarettes. Smokers with the VLNC misperception were more likely to report that they would be less likely to quit compared to those without the VLNC misperception (32.0% vs. 15.8%, p < .01).
DISCUSSION
Nearly half of US smokers had the misperception that very low nicotine cigarettes are less likely to cause cancer than current cigarettes. This was higher than the 30% rate that O’Brien and colleagues found when asking US smokers and nonsmokers about the harmfulness of “a cigarette advertised as ‘low nicotine’” compared to a typical cigarette.[19] The difference in results may reflect the way people think about “low” nicotine versus cigarettes with “most” of the nicotine removed, the inclusion of nonsmokers, or the difference between the framing of the survey item as an advertising claim versus a government requirement. Past health and media messages about nicotine may have primed the public to believe lower nicotine means lower toxicity.[17,23] Incorrect perceptions about nicotine could also discourage use of safer nicotine products for smoking cessation, the other goal of FDA’s new approach.[2] We did not find the hypothesized correlation between the VLNC misperception and educational attainment. This may indicate that people learn about nicotine in cigarettes informally, outside of the education system. We found the misperception may be more common among black smokers than white smokers, a finding opposite to that of O’Brien and colleagues.[19] Further research on different beliefs among races may be necessary in order to develop communication campaigns that narrow rather than widen any racial disparities in these misperceptions. We also found that nearly a quarter of smokers reported that they would be less likely to quit smoking if FDA enacted a VLNC standard. This behavioral prediction was associated with the VLNC misperception, suggesting that the belief that VLNC cigarettes are less harmful may reduce motivation to quit among a substantial number of smokers.
A limitation of our study is that the survey was necessarily presenting a hypothetical situation because the US does not presently have a VLNC policy in place. However, our study offers an important contribution by proactively investigating the prevalence of the VLNC misperception; regulators can prepare messaging in advance, aiming to minimize the potential unintended consequence of reducing smokers’ intentions to quit. Future research should examine the causal association between having the VLNC misperception and quitting intentions and behavior, interactions with other motivators of quitting, and perceived risk of VLNC cigarettes for health problems other than lung cancer. Additionally, researchers can investigate how the VLNC misperception and incorrect beliefs about nicotine affect interest in alternative nicotine products such as e-cigarettes.[24]
Countries that enact a VLNC standard should be prepared for possible unintended consequences of reducing the perceived risk of smoking. A communication campaign may strengthen the rollout of a VLNC policy by conveying to smokers that, while likely less addictive, VLNC cigarettes are just as toxic as current cigarettes.
WHAT THIS PAPER ADDS.
The US is considering a strategy to lower the nicotine content in cigarettes to non-addictive levels in order to reduce smoking and related deaths.
If smokers see very low nicotine content (VLNC) cigarettes as less carcinogenic than current cigarettes, they may have less motivation to quit or to switch to a safer source of nicotine.
In the first nationally-representative survey of public beliefs about the carcinogenicity of VLNC cigarettes, 47% of smokers incorrectly thought that smoking these cigarettes is less likely to cause cancer than smoking current cigarettes. A quarter reported that they would be less likely to quit smoking if the US enacted a VLNC standard.
A VLNC standard may be more effective if accompanied by a communication campaign to reduce misperceptions about VLNC cigarettes and nicotine.
Acknowledgments
We thank the Carolina Survey Research Laboratory and the members of the Center for Regulatory Research on Tobacco Control for their assistance in data collection.
Funding: Research reported in this publication was supported by grant number P50CA180907 from the National Cancer Institute and the FDA Center for Tobacco Products (CTP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.
Footnotes
Competing Interests: Dr. Brewer has served as a paid expert consultant in litigation against tobacco companies. The other authors declare no conflicts of interest.
Ethical Review: The protocol and related materials for this study were approved by the University of North Carolina Institutional Review Board.
Contribution Statement: MJB and NTB led instrument development, data collection, and data analysis. MJB led writing. All authors contributed substantively to conceptualizing, writing, revising, and final review of this manuscript.
References
- 1.U.S. Food and Drug Administration. FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death. FDA News Release. 2017 Jul 28; [Google Scholar]
- 2.Gottlieb S, Zeller M. A nicotine-focused framework for public health. N Engl J Med. 2017;377(12):1111–1114. doi: 10.1056/NEJMp1707409. [DOI] [PubMed] [Google Scholar]
- 3.Benowitz NL, Henningfield JE. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med. 1994;331(2):123–125. doi: 10.1056/NEJM199407143310212. [DOI] [PubMed] [Google Scholar]
- 4.WHO Study Group on Tobacco Product Regulation (TobReg) Advisory Note: Global Nicotine Reduction Strategy. Geneva: World Health Organization; 2015. [Google Scholar]
- 5.Donny EC, Walker N, Hatsukami D, et al. Reducing the nicotine content of combusted tobacco products sold in New Zealand. Tob Control. 2016 doi: 10.1136/tobaccocontrol-2016-053186. [DOI] [PubMed] [Google Scholar]
- 6.Donny EC, Denlinger RL, Tidey JW, et al. Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med. 2015;373(14):1340–1349. doi: 10.1056/NEJMsa1502403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hatsukami DK, Donny EC, Koopmeiners JS, et al. Compensatory smoking from gradual and immediate reduction in cigarette nicotine content. Cancer Epidemiol Biomarkers Prev. 2015;24(2):472–476. doi: 10.1158/1055-9965.EPI-14-0739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Walker N, Fraser T, Howe C, et al. Abrupt nicotine reduction as an endgame policy: a randomised trial. Tob Control. 2015;24(e4):e251–257. doi: 10.1136/tobaccocontrol-2014-051801. [DOI] [PubMed] [Google Scholar]
- 9.Benowitz NL, Hall SM, Stewart S, et al. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2479–2485. doi: 10.1158/1055-9965.EPI-07-0393. [DOI] [PubMed] [Google Scholar]
- 10.Hatsukami DK, Kotlyar M, Hertsgaard LA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction. 2010;105(2):343–355. doi: 10.1111/j.1360-0443.2009.02780.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Benowitz NL, Dains KM, Hall SM, et al. Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev. 2012;21(5):761–769. doi: 10.1158/1055-9965.EPI-11-0644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hatsukami DK, Hertsgaard LA, Vogel RI, et al. Reduced nicotine content cigarettes and nicotine patch. Cancer Epidemiol Biomarkers Prev. 2013;22(6):1015–1024. doi: 10.1158/1055-9965.EPI-12-1439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Pearson JL, Abrams DB, Niaura RS, et al. Public support for mandated nicotine reduction in cigarettes. Am J Public Health. 2013;103(3):562–567. doi: 10.2105/AJPH.2012.300890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.111th Congress of the United States of America. Family Smoking Prevention and Tobacco Control Act, Public Law 111–31, 123 Statute 1776. 2009 Jun 22; Available online at: http://www.gpo.gov/fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf.
- 15.Blackwell T. National Post. Ontario, Canada: 2016. Health Canada looks at forcing tobacco companies to make cigarettes less addictive. [Google Scholar]
- 16.Hatsukami DK, Benowitz NL, Donny E, et al. Nicotine reduction: strategic research plan. Nicotine Tob Res. 2013;15(6):1003–1013. doi: 10.1093/ntr/nts214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Johnson SE. What the public knows and believes about nicotine: Insights from recent quantitative and qualitative evidence. FDA Center for Tobacco Products presentation about PATH survey data. 22nd Annual Meeting of the Society for Research on Nicotine and Tobacco; Chicago, IL: FDA Center for Tobacco Products; 2016. [Google Scholar]
- 18.Denlinger-Apte RL, Joel DL, Strasser AA, et al. Low nicotine content descriptors reduce perceived health risks and positive cigarette ratings in participants using very low nicotine content cigarettes. Nicotine Tob Res. 2016 doi: 10.1093/ntr/ntw320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.O’Brien EK, Nguyen AB, Persoskie A, et al. U.S. adults’ addiction and harm beliefs about nicotine and low nicotine cigarettes. Prev Med. 2016;96:94–100. doi: 10.1016/j.ypmed.2016.12.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Boynton MH, Agans RP, Bowling JM, et al. Understanding how perceptions of tobacco constituents and the FDA relate to effective and credible tobacco risk messaging: A national phone survey of U.S. adults, 2014–2015. BMC Public Health. 2016;(16):516. doi: 10.1186/s12889-016-3151-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Baig SA, Moracco KE, Agans RP, et al. Developing effective messages about the chemicals in cigarette smoke: The role of reactance and education. In preparation. [Google Scholar]
- 22.Centers for Disease Control and Prevention. Current Cigarette Smoking Among Adults—United States, 2005–2014. Morbidity and Mortality Weekly Report. 2015;64(44):1233–1240. doi: 10.15585/mmwr.mm6444a2. [DOI] [PubMed] [Google Scholar]
- 23.Mumford EA, Pearson JL, Villanti AC, et al. Nicotine and E-cigarette Beliefs and Policy Support among US Smokers and Nonsmokers. Tobacco Regulatory Science. 2017;3(3):293–305. [Google Scholar]
- 24.Benowitz NL, Donny EC, Hatsukami DK. Reduced nicotine content cigarettes, e-cigarettes and the cigarette end game. Addiction. 2017;112(1):6–7. doi: 10.1111/add.13534. [DOI] [PMC free article] [PubMed] [Google Scholar]